Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Depreciation & Amortization (CF) (2020 - 2025)

Historic Depreciation & Amortization (CF) for Aveanna Healthcare Holdings (AVAH) over the last 6 years, with Q3 2025 value amounting to $2.6 million.

  • Aveanna Healthcare Holdings' Depreciation & Amortization (CF) rose 46.39% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year decrease of 1170.8%. This contributed to the annual value of $10.8 million for FY2024, which is 2177.38% down from last year.
  • As of Q3 2025, Aveanna Healthcare Holdings' Depreciation & Amortization (CF) stood at $2.6 million, which was up 46.39% from $2.6 million recorded in Q2 2025.
  • In the past 5 years, Aveanna Healthcare Holdings' Depreciation & Amortization (CF) registered a high of $8.2 million during Q1 2022, and its lowest value of $2.4 million during Q4 2024.
  • Its 5-year average for Depreciation & Amortization (CF) is $4.1 million, with a median of $3.5 million in 2023.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first surged by 3118.31% in 2021, then crashed by 4472.05% in 2022.
  • Quarter analysis of 5 years shows Aveanna Healthcare Holdings' Depreciation & Amortization (CF) stood at $5.1 million in 2021, then fell by 11.78% to $4.5 million in 2022, then dropped by 27.65% to $3.3 million in 2023, then dropped by 25.52% to $2.4 million in 2024, then grew by 6.26% to $2.6 million in 2025.
  • Its last three reported values are $2.6 million in Q3 2025, $2.6 million for Q2 2025, and $2.6 million during Q1 2025.